Moderna’s Combo Vax Hits a Roadblock

Moderna just yanked its FDA application for their much-hyped combo flu/COVID shot, even after saying it worked better than current vaccines. Turns out, the FDA wants more data, so Moderna’s pushing approval back to 2026 and deprioritizing the shot for now. Their stock dropped 4.5% on the news. They’ll try again later this year when more trial results come in. Meanwhile, the FDA’s getting stricter on vaccine approvals, and Pfizer’s racing ahead with its own combo vax. Wild times in vaccine land! #Moderna #VaccineNews #Biotech #FDA #COVID19 #Health